Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Vaccine, Mlv, Borrelia Burgdorferi Bacterin-Lepto Cani-Grippo-Ictero-Pomona Bacterial Extract
344 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
344
Total Reports
16
Deaths Reported
470.0%
Death Rate
Active Ingredients
Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Vaccine, Mlv, Borrelia Burgdorferi Bacterin-Lepto Cani-Grippo-Ictero-Pomona Bacterial Extract
Administration Routes
SubcutaneousParenteralUnknownOralOther
Species Affected
Dog 344
Most Affected Breeds
Retriever - Labrador 64
Retriever - Golden 30
Mountain Dog - Bernese 17
Shepherd Dog - Australian 14
Shepherd Dog - German 12
Terrier - Yorkshire 11
Beagle 10
Siberian Husky 10
Crossbred Canine/dog 10
Shih Tzu 9
Most Reported Reactions
Lack of efficacy (bacteria) - Borrelia 185
Lack of efficacy (ectoparasite) - tick NOS 78
Other abnormal test result NOS 58
Vomiting 34
Partial lack of efficacy 33
Lethargy (see also Central nervous system depression in 'Neurological') 20
Diarrhoea 19
Lack of efficacy (bacteria) - Anaplasma 16
Lethargy (see also Central nervous system depression in Neurological) 15
Leucocytosis NOS 12
Death by euthanasia 12
Facial swelling (see also 'Skin') 11
Outcome Breakdown
Outcome Unknown
253 (73.5%)
Recovered/Normal
42 (12.2%)
Ongoing
33 (9.6%)
Euthanized
12 (3.5%)
Died
4 (1.2%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.